Patrick John Finn - Dec 21, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Stock symbol
TWST
Transactions as of
Dec 21, 2021
Transactions value $
-$13,035
Form type
4
Date filed
12/23/2021, 03:35 PM
Previous filing
Dec 6, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $5.11K +219 +0.57% $23.33 38.5K Dec 21, 2021 Direct
transaction TWST Common Stock Sale -$18.1K -219 -0.57% $82.85 38.2K Dec 21, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -219 -1.08% $0.00 20K Dec 21, 2021 Common Stock 219 $23.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
F2 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.